NCT05227404View on ClinicalTrials.gov

Evaluation of Point-of-Care (EPOC) for COVID-19

CompletedOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

September 2, 2022

Study Completion Date

September 2, 2022

Conditions
COVID-19SARS CoV 2 Infection
Interventions
DIAGNOSTIC_TEST

LumiraDX

Point-of-care test for SARS-CoV-2

DIAGNOSTIC_TEST

RightSign

Point-of-care test for SARS-CoV-2

DIAGNOSTIC_TEST

Case Control

Genscript assay performed on the plasma sample

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER